Tech Center 3700 • Art Units: 1611 1612 1615 1616 1617 3774
This examiner grants 84% of resolved cases
Carlos A. Azpuru, working in Art Unit 1611 within Tech Center 3700, has handled a volume of 1297 resolved cases. His allowance rate of 83.8% indicates a high probability of success for applications assigned to his docket. The median days to allowance stands at 965, providing a clear benchmark for the expected duration of the prosecution process.
The data shows an interview lift of 10.7% over the 83.8% baseline, which provides a moderate boost to the chances of success. For practitioners, this suggests that while written arguments are often successful, an interview can be a valuable tool to resolve final disagreements. Managing 1297 resolved cases demonstrates significant experience, and the 965-day timeline suggests a consistent pace of resolution. Applicants can feel confident in the high baseline of success while using interviews strategically to further improve their odds beyond the initial 83.8% rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19562371 | OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR | Non-Final OA | OCULAR THERAPEUTIX, INC. |
| 18733177 | DEODORANT AND ANTIPERSPIRANT COMPOSITIONS | Non-Final OA | The Procter & Gamble Company |
| 18443360 | COSMETIC INK COMPOSITION COMPRISING A SURFACE TENSION MODIFIER | Non-Final OA | The Procter & Gamble Company |
| 18599800 | USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION | Non-Final OA | Allergan, Inc. |
| 18402685 | SYSTEMS AND METHODS TO ACCELERATE GEL-SOL TRANSITION FOR THERMORESPONSIVE HYDROGELS | Non-Final OA | University of Southern California |
| 18790605 | SYSTEM AND METHOD OF ATTACHING SOFT TISSUE TO AN IMPLANT | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 18695487 | COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS | Non-Final OA | The Trustees Of The University of Pennsylvania |
| 18682824 | METHOD FOR TREATING ENDOMETRIOSIS AND PROVIDING EFFECTIVE CONTRACEPTION | Non-Final OA | CHEMO RESEARCH, S.L. |
| 18409546 | LIPID PRODRUGS OF NEUROSTEROIDS | Non-Final OA | Monash University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy